Agran Libbie’s Pfizer PFE Stock Holding History

Agran Libbie’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$314K	Buy	+9,674	New	+$305K	0.07%	107

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Agran Libbie's PFE Position: Q1 2017 in Review

Agran Libbie opened a new position in Pfizer (PFE) in Q1 2017: 9,674 shares worth $314K. The stake represents 0.07% of the portfolio and ranks #107 among its holdings.

2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

Agran Libbie held 9,674 shares of Pfizer worth $314K as of Q1 2017.
Pfizer was a new Agran Libbie position in Q1 2017.
Pfizer made up 0.07% of Agran Libbie's portfolio in Q1 2017, its #107 holding.
2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Agran Libbie's 13F filing for Q1 2017, filed 27 Apr 2017.